Pinned Tweet
🚀Big News! Beacon Biosignals has acquired Dreem, a leader in at-home sleep monitoring. This pivotal move brings together Dreem's innovative tech & our advanced EEG analytics platform to enhance clinical trials at scale. Exciting times ahead!
beacon.bio/press-releases/be…
Beacon Biosignals retweeted
Measuring brainwaves during sleep is measuring waste clearance from the brain! Beautiful work in Nature by Kipnis’ group linking synchronized neural activity & glymphatic flow to clear brain parenchyma, showing potential role in neurodegenerative disease
nature.com/articles/s41586-0…
Beacon Biosignals retweeted
No Moonshots with Paper Plans: #Alzheimers Research Needs #Neurotech
My latest in @Forbes with a quick look at the work of
@altoida @Koneksa @biosignals @KernelCo @CumulusNeuro @startuphealth and others to bring dementia research into the 21st century
forbes.com/sites/naveenrao/2…
We’re thrilled to welcome Dr. David Matthews as Beacon’s newly appointed Chief Business Officer! David has a scientific background in neuro and AI, and has helped commercialize breakthrough treatments and products that improve patients' lives.
lnkd.in/gnBEuau2 @e2pi
Beacon Biosignals retweeted
Excited to partner with @GateNeuro for a Phase 2 trial on zelquistinel to treat major depressive disorder! 🚀 Leveraging FDA-cleared Dreem 3S headband & our AI Analytics, we're bringing precision to psychiatry with novel EEG biomarkers and sleep endpoints!
businesswire.com/news/home/2…
Excited to partner with @GateNeuro for a Phase 2 trial on zelquistinel to treat major depressive disorder! 🚀 Leveraging FDA-cleared Dreem 3S headband & our AI Analytics, we're bringing precision to psychiatry with novel EEG biomarkers and sleep endpoints!
businesswire.com/news/home/2…
We are actively seeking a skilled data scientist with a strong background in stats and large datasets. If this sounds like you or someone you know, check out the job description on our website!
beacon.bio/careers
lnkd.in/gwCtvpKb
Beacon Biosignals retweeted
Did you know you can scratch in your sleep without waking up, especially during nREM stages 1 & 2? Individuals with Atopic Dermatitis (AtD) have increased nocturnal scratching, especially in areas of skin flexion including the wrist.
#atopicdermatitis #sleep #EEG #PSG #Dreem
Did you know you can scratch in your sleep without waking up, especially during nREM stages 1 & 2? Individuals with Atopic Dermatitis (AtD) have increased nocturnal scratching, especially in areas of skin flexion including the wrist.
#atopicdermatitis #sleep #EEG #PSG #Dreem
Beacon Biosignals retweeted
Replying to @biosignals
@Biosignals' @Jake_Donoghue shares how his company's EEG #neurobiomarker platform holds the potential to accelerate #clinicaltrials and ultimately enable new treatment options for #psychiatric diseases. #CNSSummit2023
Beacon Biosignals retweeted
Why every #RareDisease pt w/ epilepsy needs a personal repository of their own #EEG in .edf format.
Shououts to @epilepsia @biosignals @cureangelman @scn2agene
Feedback on this crazy idea welcome!
Episode: #S10e123
Pod: #SYNGAP10
Gene: #SYNGAP1
Organization: @cureSYNGAP1
Listen to the latest #SYNGAP10 episode with @jmgraglia! What is #SynGAPResearchFund doing to help #SYNGAP1 families this week? Subscribe to the #podcast at Syngap.fund/10 podbean.com/eas/pb-2vnm7-14e… #SYNGAP1
At #worldsleep2023, @IdorsiaUS and Beacon released exciting results of the effect of daridorexant on sleep microarchitecture in patients with insomnia from the Ph 3 Studies!
See the full poster here:Â bitly.ws/YX9W
Beacon Biosignals retweeted
The FDA has granted 510(k) clearance for @biosignals’ Dreem 3S, a wearable headband with integrated machine-learning algorithms to capture #EEG data from the brain to monitor #sleep architecture and aid in the diagnosis of disturbed sleep buff.ly/3PYkvwc
Our recent work in BMC Neurology shows that algorithmically capturing the sleep spindles provides a superior method to characterization, compared to averaging NREM2 sigma power.
Full Article:
🔗 lnkd.in/ec3ug8y7
#eeg #psg #sleep #spindles #NREM2 #biopharma

























